1H-Indazol-6-amine → 2-hydroxy-N-(indazol-6-yl)-5-(4-methoxyphenylazo)benzamide

HRID 613949

Reaktionsgleichung

Reaktionsgleichung von HRID 613949
[CH3:1][O:2][C:3]1[CH:8]=[CH:7][C:6]([N:9]=[N:10][C:11]2[CH:19]=[C:15]([C:16](Cl)=[O:17])[C:14]([OH:20])=[CH:13][CH:12]=2)=[CH:5][CH:4]=1.[NH2:21][C:22]1[CH:30]=[C:29]2[C:25]([CH:26]=[N:27][NH:28]2)=[CH:24][CH:23]=1>>[OH:20][C:14]1[CH:13]=[CH:12][C:11]([N:10]=[N:9][C:6]2[CH:7]=[CH:8][C:3]([O:2][CH3:1])=[CH:4][CH:5]=2)=[CH:19][C:15]=1[C:16]([NH:21][C:22]1[CH:30]=[C:29]2[C:25]([CH:26]=[N:27][NH:28]2)=[CH:24][CH:23]=1)=[O:17]

Komponenten

3

Edukt 2

HCID 814231H-Indazol-6-amineHCID 1355740405-(4-Methoxyphenylazo)salicoyl chloride

Produkt 1

HCID 1355740332-hydroxy-N-(indazol-6-yl)-5-(4-methoxyphenylazo)benzamide

Versuchsvorschrift

5-(4-Methoxyphenylazo)salicoyl chloride and 6-aminoindazole were reacted together as described in Preparation 7. The product was crystallized in aqueous pyridine, m.p. 279°, λmax (methanol) = 350 nm.

Aufarbeitung

  1. customas described in Preparation 7
  2. customThe product was crystallized in aqueous pyridine

Quellen und Nachweise

ORD-Eintrag
ord-aed17650dd984b31aa46ec4862554e06
Quelldatensatz
uspto-grants-1979_03
Patentnummer
US04142901

Verknüpfte Notizen

Wird geladen…